A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined Inclusion/Exclusion Criteria may apply.
medinfo@incyte.com1.855.463.3463
eumedinfo@incyte.com+800 00027423
Birmingham, Alabama 35233, United States
Tucson, Arizona 85718, United States
Fayetteville, Arkansas 72703, United States
Los Angeles, California 90036-5609, United States
Rolling Hills Estates, California 90274-7604, United States
Albuquerque, New Mexico 87102, United States
Bellaire, Texas 77401, United States
Calgary, Alberta T3B 6A8, Canada
Toronto, Ontario M5G1X8, Canada
Montreal, Quebec H3T 1C5, Canada
Québec, Quebec G1V 4G2, Canada